Vem İlaç

Vem İlaç is a leading Turkish pharmaceutical company, established in 2000, that specializes in the development and manufacturing of a broad range of high-quality generic medicinal products. The company operates state-of-the-art production facilities in the Çerkezköy Organized Industrial Zone, featuring advanced capabilities in sterile liquid forms, lyophilization, and Blow-Fill-Seal (BFS) technology. Their diverse portfolio addresses critical medical needs across multiple therapeutic areas, including anesthesia, intensive care, nephrology, cardiology, and respiratory medicine. Vem İlaç is a significant player in both domestic and international markets, exporting its products to numerous countries in Europe, the Middle East, and Africa. Notably, the company has expanded its focus to include value-added generics and biosimilars, supported by robust R&D and international partnerships.